-
Pembrolizumab (breast cancer, triple-negative, neoadjuvant and adjuvant): Benefit assessment according to §35a SGB V (expiry of the decision): IQWiG Reports – Commission No. A24-104 [Internet].
Institute for Quality and Efficiency in Health Care (IQWiG).
Cologne (Germany): Institute for Quality and Efficiency in Health Care (IQWiG); 2024 Dec 20.
-
Comparing Bladder Management Strategies for People with Spinal Cord Injuries [Internet].
Myers JB, Lenherr SM, Stoffel J, et al.
Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2020 Jun.
-
How Do Patients Feel about Sharing and Linking Health Data for Research? [Internet].
O'Brien SM, O'Brien E, Lucas J, et al.
Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2020 Jul.
-
Comparing the Safety and Effectiveness of Low-Dose versus High-Dose Aspirin to Prevent Problems from Heart Disease -- The ADAPTABLE Study -- A PCORnet® Study [Internet].
Jones WS, Sharlow AG, Wruck LM, et al.
Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2023 Oct.
-
Comparing Acupuncture and Cognitive Behavioral Therapy to Treat Insomnia among Cancer Survivors—The CHOICE Trial [Internet].
Mao JJ, Li Q, Garland SN, et al.
Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2020 Jul.
See more...
Image credit: SEM Penicillium mold and spores; David Gregory and Debbie Marshall, Wellcome Images